Skip to main content
Log in

Concentration- and rate-dependent electrophysiological effects of restacorin on isolated canine purkinje fibres

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

The cellular electrophysiological effects of restacorin, a new antiarrhythmic agent were studied using conventional microelectrode techniques in isolated dog cardiac Purkinje fibres. Restacorin (1 – 30 µmol/l) decreased the maximum rate of rise of the action potential upstroke and action potential amplitude while action potential duration measured at 90% of repolarization was shortened in a concentration-dependent manner during pacing at a constant basic cycle length of 500 ms. The effect of 10 µmol/l restacorin on maximal rate of rise of the action potential upstroke and on action potential duration measured at 90% of repolarization were also studied while varying the constant pacing cycle length between 300 and 5000 ms. The results of these studies indicated a rate-dependent effect of restacorin on the action potential characteristics examined. After abrupt changes in cycle length, 10 µmol/l restacorin slowed the fast component of the relation for restitution of action potential duration from 155.3 ± 5.2 ms (control, n = 6) to 217.1 ± 17.8 ms (n = 6, P < 0.05). In the presence of restacorin (10 µmol/l), a second slow component for recovery of maximal action potential up stroke rising velocity was expressed having a time constants of 8.5 ± 1.2 s. The range of premature action potential durations was significantly decreased (by 57.1%, P < 0.01) by 10 µmol/l restacorin. These results indicate that the cellular electrophysiological effects produced by restacorin in dog cardiac Purkinje fibres best resemble those produced by recognized class Ic antiarrhythmic drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Arita M, Goto M, Nagamoto Y, Saikawa T (1979) Electrophysiological actions of mexiletine (Kö 1173) on canine Purkinje fibers and ventricular muscle. Br J Pharmacol 67:143–152

    CAS  PubMed  Google Scholar 

  • Attwell D, Cohen I, Eisner D, Ohba M, Ojeda C (1979) The steady state TTX-sensitive (“window”) sodium current in cardiac Purkinje fibres. Pflügers Arch 379:137–142

    Article  CAS  PubMed  Google Scholar 

  • Bigger JT, Mandel WJ (1970) Effect of lidocaine on the electrophysiological properties of ventricular muscle and Purkinje fibers. J Clin Invest 49:62–77

    Google Scholar 

  • Campbell TJ (1983) Resting and rate-dependent depression of maximum rate of depolarization (\(\dot V\) max) in guinea pig ventricular action potentials by mexiletine, disopyramide, and encainide. J Cardiovasc Pharmacol 5:291–296

    CAS  PubMed  Google Scholar 

  • Chen C-M, Gettes LS, Katzung BG (1975) Effects of lidocaine and quinidine on the steady state characteristics and recovery kinetics (dV/dt)max in guinea pig ventricular myocardium. Circ Res 37:20–29

    CAS  PubMed  Google Scholar 

  • Cohen CJ, Bean BP, Tsien RW (1984) Maximal upstroke velocity as an index of available sodium conductance. Circ Res 54:636–651

    CAS  PubMed  Google Scholar 

  • Courtney K (1980) Interval-dependent effects of small antiarrhythmic drugs on excitability of guinea-pig myocardium. J Mol Cell Cardiol 12:1273–1286

    Article  CAS  PubMed  Google Scholar 

  • DeLean A, Munson PJ, Rodbard D (1978) Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 235:E97-E102

    CAS  PubMed  Google Scholar 

  • Elharrar V (1988) Recovery from use-dependent block of \(\dot V\) max and restitution of action potential duration in canine cardiac Purkinje fibers. J Pharmacol Exp Ther 246:235–242

    CAS  PubMed  Google Scholar 

  • Elharrar V, Surawicz B (1983) Cycle length effect on restitution of action potential duration in dog cardiac fibers. Am J Physiol 244:H782-H792

    CAS  PubMed  Google Scholar 

  • Gibson JK, Somani P, Bassett AL (1978) Electrophysiologic effects of encainide (MJ 9067) on canine Purkinje fibers. Eur J Pharmacol 52:161–169

    Article  CAS  PubMed  Google Scholar 

  • Heistracher P (1971) Mechanism of action of antifibrillatory Drugs. Naunyn-Schmiedeberg's Arch Pharmacol 269:199–212

    CAS  Google Scholar 

  • Hiraoka M, Kawano S (1987) Calcium-sensitive and insensitive transient outward current in rabbit ventricular myocytes. J Physiol (Lond) 410:187–212

    Google Scholar 

  • Hoffman BF, Rosen MR (1981) Cellular mechanisms for cardiac arrhythmias. Circ Res 49:1–15

    CAS  PubMed  Google Scholar 

  • Hohnloser S, Weirich J, Antoni H (1982) Effects of mexiletine on steady-state characteristics and recovery kinetics of \(\dot V\) max and conduction velocity in guinea pig myocardium. J Cardiovasc Pharmacol 4:232–239

    CAS  PubMed  Google Scholar 

  • Hondeghem LM, Katzung BG (1984) Antiarrhythmic agents: the modulated receptor mechanism of action of sodium and calcium channel-blocking drugs. Ann Rev Pharmacol Toxicol 24:387–423

    CAS  Google Scholar 

  • Ikeda N, Singh BN, Davis LD, Hauswirth O (1985) Effects of flecainide on the electrophysiological propeties of isolated canine and rabbit myocardial fibers. J Am Coll Cardiol 5:303–310

    CAS  Google Scholar 

  • Imaizumi Y, Giles WR (1987) Quinidine-induced inhibition of transient outward current in cardiac muscle. Am J Physiol 253:H704-H708

    CAS  PubMed  Google Scholar 

  • Johnson EA, McKinnon MG (1957) The differential effect of quinidine and pyrilamine on the myocardial action potential at various rates of stimulation. J Pharmacol Exp Ther 120:460–468

    CAS  PubMed  Google Scholar 

  • Kodama I, Morimoto M, Toyama J, Shibata S (1989) Electrophysiologic effects of TYB-2823, a new antiarrhytmic agent on isolated guinea pig ventricular muscles. J Cardiovasc Pharmacol 13:616–623

    CAS  PubMed  Google Scholar 

  • Kohlhardt M, Seifert C (1985) Properties of \(\dot V\) max block of INa-mediated action potentials during combined application of antiarrhythmic drugs in cardiac muscle. Naunyn-Schmiedeberg's Arch Pharmacol 330:235–244

    Article  CAS  Google Scholar 

  • Kuo C-S, Amlie JP, Munakata K, Reddy CP, Surawicz B (1983a) Dispersion of monophasic action potential durations and activation times during atrial pacing, ventricular pacing, and ventricular premature stimulation in canine ventricles. Cardiovasc Res 17:152–161

    CAS  PubMed  Google Scholar 

  • Kuo C-S, Amlie JP, Munakata K, Reddy CP, Surawicz B (1983b) Characteristics and possible mechanism of ventricular arrhyth mia dependent on the dispersion of action potential durations. Circulation 67:1356–1367

    CAS  PubMed  Google Scholar 

  • Kurthy M, Rabloczky G, Varró A, Szatmary LJ, Jaszlits L, Wellmann J, Erczy I (1985) New antiarrhythmic agent with positive cardiac actions (GYKI-38 233). In: Szekeres L and Papp JGY (eds) Advances in Pharmacological Research and Practice, Proceedings of the 4th Congress of the Hungarian Pharmacological Society, Budapest 1985, Vol 1. Pergamon Oxford, Akademiai Kiado Budapest, pp. 221–215

    Google Scholar 

  • Kus T, Sasyniuk BI (1978) The electrophysiological effects of disopyramide on canine ventricular muscle and Purkinje fibers in normal and low potassium. Can J Physiol Pharmacol 56:139–149

    CAS  PubMed  Google Scholar 

  • Lathrop DA, Varró A, Schwartz A (1989) Rate-dependent electrophysiological effects of OPC-8212: comparison to sotalol. Eur J Pharmacol 164:487–496

    Article  CAS  PubMed  Google Scholar 

  • Nattel S, Zeng F-D (1984) Frequency-dependent effects of antiarrhythmic drugs on action potential duration and refractoriness of canine cardiac Purkinje fibers. J Pharmacol Exp Ther 229:283–291

    CAS  PubMed  Google Scholar 

  • Ohmura T, Hayashi H, Muramatsu I (1988) Antiarrhythmic and hemodynamic effect of a new antiarrhythmic drug, TYB-3823, in dogs and rats. Jpn J Pharmacol 46:211

    Google Scholar 

  • Rabloczky G, Varró A, Kurthy M, Bodi I, Jednakovits A, Szathmary L, Jaszlits L, Kiraly I (1988) Pharmacology of BGYKI-38 233, a new antiarrhythmic agent. Pharmacol Res Commun 20:Suppl I 71–72

    Google Scholar 

  • Rosen MR, Merker C, Gelband H, Hoffman BF (1973) Effects of procaine amide on the electrophysiological properties of the canine ventricular conducting system. J Pharmacol Exp Ther 185:438–446

    CAS  PubMed  Google Scholar 

  • Sada H, Kohima M, Bant T (1979) Effects of procainamide on transmembrane action potentials in guinea-pig papillary muscles as affected by external potassium concentration. Naunyn-Schmiedeberg's Arch Pharmacol 309:179–190

    Article  CAS  Google Scholar 

  • Sada H, Kojima M, Ban T (1980) Effects of tocainide and lidocaine in the transmembrane action potentials as related to external potassium and calcium concentrations in guinea-pig papillary muscles. Naunyn-Schmiedeberg's Arch Pharmacol 314:67–82

    Google Scholar 

  • Starmer CF, Grant AO, Strauss HC (1984) Mechanisms of use-dependent block of sodium channels in excitable membranes by local anaesthetics. Biophys J 46:15–27

    CAS  PubMed  Google Scholar 

  • Tritthart H, Fleckenstein B, Fleckenstein A (1971) Some fundamental actions of antiarrhythmic drugs on the excitability and contractility of single myocardial fibers. Naunyn-Schmiedeberg's Arch Pharmacol 269:212–219

    CAS  Google Scholar 

  • Varró A, Elharrar V, Surawicz B (1985a) Frequency-dependent effects of several class I antiarrhythmic drugs on (\(\dot V\) max) of action potential upstroke in canine cardiac Purkinje fibers. J Cardiovasc Pharmacol 7:482–492

    PubMed  Google Scholar 

  • Varró A, Elharrar V, Surawicz B (1985b) Effect of antiarrhythmic drugs on the premature action potential duration in canine cardiac Purkinje fibers. J Pharmacol Exp Ther 233:304–311

    Google Scholar 

  • Varró A, Nakaya Y, Elharrar V, Surawicz B (1986) Effect of antiarrhythmic drugs on the cycle length-dependent action potential duration in dog Purkinje and ventricular muscle fibers. J Cardiovasc Pharmacol 8:178–185

    PubMed  Google Scholar 

  • Wang CM, Parker CH (1980) Reassessment of electrophysiological effects of the antiarrhythmic agent quinidine in canine Purkinje fibers. Life Sci 27:663–670

    CAS  PubMed  Google Scholar 

  • West TC, Amory DW (1960) Single fiber recording of the effects of quinidine at atrial and pacemaker sites in the isolated right atrium of the rabbit. J Pharmacol Exp Ther 130:183–193

    CAS  PubMed  Google Scholar 

  • Zipes DP (1988) Management of cardiac arrhythmias: Pharmacological, electrical and surgical techniques. In: Braunwald E (ed) Heart disease: A textbook of cardiovascular medicine. Saunders, Philadelphia, pp 621–657

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Varrò, A., Knilans, T.K., Nànàsi, P.P. et al. Concentration- and rate-dependent electrophysiological effects of restacorin on isolated canine purkinje fibres. Naunyn-Schmiedeberg's Arch Pharmacol 342, 691–697 (1990). https://doi.org/10.1007/BF00175714

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00175714

Key words

Navigation